Stanniocalcin 2 (STC2) is a potent biomarker of hepatocellular carcinoma with its expression being augmented in Nrf1α-deficient cells, but diminished in Nrf2-deficient cells
Q. Bu, Y. Deng, Q. Wang, R. Deng, S. Hu, Z. Pei, Y. Zhang
The paper identifies STC2 as a biomarker for hepatocellular carcinoma, showing its expression is increased in Nrf1α-deficient cells and decreased in Nrf2-deficient cells, with STC2 promoting tumor growth.
bioRxiv · May 15, 2023 · PreprintCell Biology